Yih-Chih Hsu
Yih-Chih Hsu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Deng-Fu Yang
Department of Bioscience Technology, Chung Yuan Christian University, Taoyuan, Taiwan, ROC
4 shared publicationsJeng-Woei Lee
Department of Life Science, Tzu Chi University, Hualien, Taiwan, ROC
4 shared publications- Chun-Pin Chiang
Department of Dentistry, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan
3 shared publications Chia-Hung Liu
Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan
2 shared publicationsHsin-Ming Chen
Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University, Taipei, Taiwan; Department of Dentistry, National Taiwan University Hospital, College of Medicine, Taipei, Taiwan
2 shared publications- Kevin Chia-Wen Wu
Molecular Science and Technology Program Taiwan International Graduate Program Academia Sinica Taipei Taiwan
2 shared publications
Latest Publications
- Open Access
- 9 September 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (9) , 1435
Novel Pyropheophorbide Phosphatydic Acids Photosensitizer Combined EGFR siRNA Gene Therapy for Head and Neck Cancer Treatment
This study combined two novel nanomedicines, a novel LCP Pyro PA photodynamic therapy (PDT) and LCP EGFR siRNA gene therapy, to treat head and neck cancer. A novel photosensitizer, pyropheophorbide phosphatydic acids (Pyro PA), was first modified into Lipid-Calcium phosphate nanoparticles named LCP Pyro PA NPs, and targeted with aminoethylanisamide as a novel PDT photosensitizer. EGFR siRNA was encapsulated into LCP NPs to silence EGFR expression. Measured sizes of LCP EGFR siRNA NPs and LCP Pyro-PA NPs were 34.9 ± 3.0 and 20 nm respectively, and their zeta potentials were 51.8 ± 1.8 and 52.0 ± 7.6 mV respectively. In vitro studies showed that EGFR siRNA was effectively knocked down after photodynamic therapy (PDT) with significant inhibition of cancer growth. SCC4 or SAS xenografted nude mice were used to verify therapeutic efficacy. The LCP Control siRNA+PDT group of SCC4 and SAS showed significantly reduced tumor volume compared to the phosphate buffered saline (PBS) group. In the LCP-EGFR siRNA+LCP Pyro PA without light group and LCP EGFR siRNA + PBS with light group, SCC4 and SAS tumor volumes were reduced by ~140% and ~150%, respectively, compared to the PBS group. The LCP EGFR siRNA+PDT group of SCC4 and SAS tumor volumes were reduced by ~205% and ~220%, respectively, compared to the PBS group. Combined therapy showed significant tumor volume reduction compared to PBS, control siRNA, or PDT alone. QPCR results showed EGFR expression was significantly reduced after treatment with EGFR siRNA with PDT in SCC4 and SAS compared to control siRNA or PDT alone. Western blot results confirmed decreased EGFR protein expression in the combined therapy group. No toxic results were found in serum biomarkers. No inflammatory factors were found in heart, liver and kidney tissues. Results suggest that the novel LCP Pyro PA mediated PDT combined with LCP siEGFR NPs could be developed in clinical modalities for treating human head and neck cancer in the future.
- 9 September 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (9) , 1435
Open AccessNovel Pyropheophorbide Phosphatydic Acids Photosensitizer Combined EGFR siRNA Gene Therapy for Head and Neck Cancer Treatment
This study combined two novel nanomedicines, a novel LCP Pyro PA photodynamic therapy (PDT) and LCP EGFR siRNA gene therapy, to treat head and neck cancer. A novel photosensitizer, pyropheophorbide phosphatydic acids (Pyro PA), was first modified into Lipid-Calcium phosphate nanoparticles named LCP Pyro PA NPs, and targeted with aminoethylanisamide as a novel PDT photosensitizer. EGFR siRNA was encapsulated into LCP NPs to silence EGFR expression. Measured sizes of LCP EGFR siRNA NPs and LCP Pyro-PA NPs were 34.9 ± 3.0 and 20 nm respectively, and their zeta potentials were 51.8 ± 1.8 and 52.0 ± 7.6 mV respectively. In vitro studies showed that EGFR siRNA was effectively knocked down after photodynamic therapy (PDT) with significant inhibition of cancer growth. SCC4 or SAS xenografted nude mice were used to verify therapeutic efficacy. The LCP Control siRNA+PDT group of SCC4 and SAS showed significantly reduced tumor volume compared to the phosphate buffered saline (PBS) group. In the LCP-EGFR siRNA+LCP Pyro PA without light group and LCP EGFR siRNA + PBS with light group, SCC4 and SAS tumor volumes were reduced by ~140% and ~150%, respectively, compared to the PBS group. The LCP EGFR siRNA+PDT group of SCC4 and SAS tumor volumes were reduced by ~205% and ~220%, respectively, compared to the PBS group. Combined therapy showed significant tumor volume reduction compared to PBS, control siRNA, or PDT alone. QPCR results showed EGFR expression was significantly reduced after treatment with EGFR siRNA with PDT in SCC4 and SAS compared to control siRNA or PDT alone. Western blot results confirmed decreased EGFR protein expression in the combined therapy group. No toxic results were found in serum biomarkers. No inflammatory factors were found in heart, liver and kidney tissues. Results suggest that the novel LCP Pyro PA mediated PDT combined with LCP siEGFR NPs could be developed in clinical modalities for treating human head and neck cancer in the future.
- Open Access
- 1 September 2020
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 8 (35) , 8084
Correction: Biocompatible and multifunctional gold nanorods for effective photothermal therapy of oral squamous cell carcinoma
Correction for ‘Biocompatible and multifunctional gold nanorods for effective photothermal therapy of oral squamous cell carcinoma’ by Yu-Te Liao et al., J. Mater. Chem. B, 2019, 7, 4451–4460, DOI: 10.1039/C9TB00574A.
- 1 September 2020
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 8 (35) , 8084
Open AccessCorrection: Biocompatible and multifunctional gold nanorods for effective photothermal therapy of oral squamous cell carcinoma
Correction for ‘Biocompatible and multifunctional gold nanorods for effective photothermal therapy of oral squamous cell carcinoma’ by Yu-Te Liao et al., J. Mater. Chem. B, 2019, 7, 4451–4460, DOI: 10.1039/C9TB00574A.
- Open Access
- 2 December 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (12) , 2112
Effective Combined Photodynamic Therapy with Lipid Platinum Chloride Nanoparticles Therapies of Oral Squamous Carcinoma Tumor Inhibition
Encapsulating cisplatin (CDDP) into liposomes to form lipid-platinum-chloride nanoparticles (LPC NPs) has shown a promising anticancer effect in melanoma, bladder, and liver cancer models. This promising anticancer effect of LPC NPs challenges us to study its implications in combination with photodynamic therapy (PDT). Herein, we report the therapeutic efficacy of PDT+LPC on a xenograft model of oral squamous cell carcinoma (OSCC). Results showed that PDT+LPC significantly reduced the tumor volume by up to ~112%. Meanwhile, LPC, PDT+CDDP, or the CDDP group showed ~98.8%, ~73.1%, or ~39.5% volume reductions, respectively. Histological examination suggests that PDT+LPC or LPC treatment showed minimal side effects on renal damage compared to either CDDP or the PDT+CDDP group. Immunohistochemistry staining (IHC) staining on Ki-67, CD31, cleaved caspase-3, TUNEL assays, and western blots of tumor suppressor p53 confirmed consistent results. Most importantly, PDT+LPC prolonged tumor growth inhibition, which leads to minimum chemotherapy treatment administrations. Results suggest that PDT cytotoxicity provided a potent additive effect towards chemotherapy efficacy. Therefore, combined PDT with LPC NPs enhanced the therapeutic outcome in human OSCC.
- 2 December 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (12) , 2112
Open AccessEffective Combined Photodynamic Therapy with Lipid Platinum Chloride Nanoparticles Therapies of Oral Squamous Carcinoma Tumor Inhibition
Encapsulating cisplatin (CDDP) into liposomes to form lipid-platinum-chloride nanoparticles (LPC NPs) has shown a promising anticancer effect in melanoma, bladder, and liver cancer models. This promising anticancer effect of LPC NPs challenges us to study its implications in combination with photodynamic therapy (PDT). Herein, we report the therapeutic efficacy of PDT+LPC on a xenograft model of oral squamous cell carcinoma (OSCC). Results showed that PDT+LPC significantly reduced the tumor volume by up to ~112%. Meanwhile, LPC, PDT+CDDP, or the CDDP group showed ~98.8%, ~73.1%, or ~39.5% volume reductions, respectively. Histological examination suggests that PDT+LPC or LPC treatment showed minimal side effects on renal damage compared to either CDDP or the PDT+CDDP group. Immunohistochemistry staining (IHC) staining on Ki-67, CD31, cleaved caspase-3, TUNEL assays, and western blots of tumor suppressor p53 confirmed consistent results. Most importantly, PDT+LPC prolonged tumor growth inhibition, which leads to minimum chemotherapy treatment administrations. Results suggest that PDT cytotoxicity provided a potent additive effect towards chemotherapy efficacy. Therefore, combined PDT with LPC NPs enhanced the therapeutic outcome in human OSCC.
- 13 June 2019
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 7 (28) , 4451-4460
Biocompatible and multifunctional gold nanorods for effective photothermal therapy of oral squamous cell carcinoma
Herein, a cysteine-functionalized alginate was used to replace cytotoxic cetyltrimethylammonium bromide (CTAB) on gold nanorods (GNRs) by gold–thiol bonding. The characterization shows that the alginate-modified GNRs (GNR@Alg-Cys) were 137 nm in length (measured by zetasizer) with a negative surface charge (−28.4 mV). The GNR@Alg-Cys showed an intense absorption at 800 nm, indicating the potential of GNR@Alg-Cys for NIR-excited photothermal therapy (PTT). To target cancer cells, a cyclic peptide, c(RGDfK)KKK, was further modified on GNR@Alg-Cys (denoted as GNR@Alg-Cys/RGD). In vitro experiments reveal the apparently enhanced cell viability under a high dose of GNRs as well as the death of SAS-3 cell lines exposed to a single-wavelength laser (808 nm). The animal study revealed that the volume of GNR@Alg-Cys/RGD-treated laser-exposed tumor was reduced five times when compared with that in the case of the control group (PBS-treated tumor). Furthermore, the in vivo toxicity of GNR@Alg-Cys/RGD was evaluated, and no significant effect was observed on the functions of liver and kidneys after PTT.
- 13 June 2019
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 7 (28) , 4451-4460
Biocompatible and multifunctional gold nanorods for effective photothermal therapy of oral squamous cell carcinoma
Herein, a cysteine-functionalized alginate was used to replace cytotoxic cetyltrimethylammonium bromide (CTAB) on gold nanorods (GNRs) by gold–thiol bonding. The characterization shows that the alginate-modified GNRs (GNR@Alg-Cys) were 137 nm in length (measured by zetasizer) with a negative surface charge (−28.4 mV). The GNR@Alg-Cys showed an intense absorption at 800 nm, indicating the potential of GNR@Alg-Cys for NIR-excited photothermal therapy (PTT). To target cancer cells, a cyclic peptide, c(RGDfK)KKK, was further modified on GNR@Alg-Cys (denoted as GNR@Alg-Cys/RGD). In vitro experiments reveal the apparently enhanced cell viability under a high dose of GNRs as well as the death of SAS-3 cell lines exposed to a single-wavelength laser (808 nm). The animal study revealed that the volume of GNR@Alg-Cys/RGD-treated laser-exposed tumor was reduced five times when compared with that in the case of the control group (PBS-treated tumor). Furthermore, the in vivo toxicity of GNR@Alg-Cys/RGD was evaluated, and no significant effect was observed on the functions of liver and kidneys after PTT.
- 23 November 2017
- Published by Wiley in Journal of Raman Spectroscopy
- Vol. 49 (2) , 336-342
Discrimination between oral cancer and healthy cells based on the adenine signature detected by using Raman spectroscopy
We report the detection of oral cancer cells using Raman spectroscopy as a noninvasive diagnostic tool. Gold nanoparticles, synthesized by using sodium citrate as a reducing agent, were used as surface‐enhanced Raman scattering substrates to detect human oral squamous cell carcinoma cell lines (SAS and SCC4) with fibroblasts cell lines as the control. We have observed the characteristic Raman signal of adenine at 735 cm−1, which indicates the oral cancer from nucleic acid. The result showed that there were significant differences (p < .05) between oral cancer cell and normal fibroblast cell lines. To prove that adenine is a robust biomarker for cancer cells, we have also compared the Raman spectra of esophageal cancer (CE48T and CE81T) and normal (Het‐1A) cells. Significant differences (p < .05) were also observed between esophageal cancer and normal cells. The detection of adenine Raman signal from cell lines has been proven to be potential to establish a highly distinguishable Raman diagnostic method for cancer detection.
- 23 November 2017
- Published by Wiley in Journal of Raman Spectroscopy
- Vol. 49 (2) , 336-342
Discrimination between oral cancer and healthy cells based on the adenine signature detected by using Raman spectroscopy
We report the detection of oral cancer cells using Raman spectroscopy as a noninvasive diagnostic tool. Gold nanoparticles, synthesized by using sodium citrate as a reducing agent, were used as surface‐enhanced Raman scattering substrates to detect human oral squamous cell carcinoma cell lines (SAS and SCC4) with fibroblasts cell lines as the control. We have observed the characteristic Raman signal of adenine at 735 cm−1, which indicates the oral cancer from nucleic acid. The result showed that there were significant differences (p < .05) between oral cancer cell and normal fibroblast cell lines. To prove that adenine is a robust biomarker for cancer cells, we have also compared the Raman spectra of esophageal cancer (CE48T and CE81T) and normal (Het‐1A) cells. Significant differences (p < .05) were also observed between esophageal cancer and normal cells. The detection of adenine Raman signal from cell lines has been proven to be potential to establish a highly distinguishable Raman diagnostic method for cancer detection.
- Open Access
- 1 January 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24 (1) , 106-116
Nanoparticle Delivered VEGF-A siRNA Enhances Photodynamic Therapy for Head and Neck Cancer Treatment
- 1 January 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24 (1) , 106-116
Open AccessNanoparticle Delivered VEGF-A siRNA Enhances Photodynamic Therapy for Head and Neck Cancer Treatment
- 1 April 2015
- Published by Elsevier in Cancer Letters
- Vol. 359 (1) , 65-74
Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer
- 1 April 2015
- Published by Elsevier in Cancer Letters
- Vol. 359 (1) , 65-74
Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer
- 1 September 2014
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 11 (3) , 331-341
Improve efficacy of topical ALA-PDT by calcipotriol through up-regulation of coproporphyrinogen oxidase
- 1 September 2014
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 11 (3) , 331-341
Improve efficacy of topical ALA-PDT by calcipotriol through up-regulation of coproporphyrinogen oxidase
- 1 September 2014
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 113 (9) , 591-599
Topical methotrexate pretreatment enhances the therapeutic effect of topical 5-aminolevulinic acid-mediated photodynamic therapy on hamster buccal pouch precancers
- 1 September 2014
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 113 (9) , 591-599
Topical methotrexate pretreatment enhances the therapeutic effect of topical 5-aminolevulinic acid-mediated photodynamic therapy on hamster buccal pouch precancers
- 1 February 2014
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 113 (2) , 88-93
Methotrexate enhances 5-aminolevulinic acid-mediated photodynamic therapy-induced killing of human SCC4 cells by upregulation of coproporphyrinogen oxidase
- 1 February 2014
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 113 (2) , 88-93
Methotrexate enhances 5-aminolevulinic acid-mediated photodynamic therapy-induced killing of human SCC4 cells by upregulation of coproporphyrinogen oxidase